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Other names: EC 3.2.1.35; HYAL-1; NT6; LUCA1; 
LUCA-1; FUS2; Hyaluronidase-1 precursor; 
Hyaluronoglucosaminidase-1; Hs.75619; MGC45987 
Location: 3p21.3 
Local order: The gene of Hyal1 is tightly clustered 
with HYAL-2 and HYAL-3. The gene for Hyal-2, 
HYAL2, the earliest known lysosomal hyaluronidase, 
resides immediately centromeric to HYAL1. 
Note: The HYAL1 gene was identified as identical 
with LUCA-1, a candidate tumour suppressor gene, 




The HYAL1 gene contains three exons and spans 
12,492 bases (start: 50,312,324 bp to end 50,324,816 
from 13pter) oriented at the minus strand. 
Transcription 
Eight alternatively spliced transcript variants of this 
gene encoding six distinct isoforms have been 
described. The longest transcript has a length of 2,518 
bps, however it is not translated to protein, since, by 
retaining intron 1 (occurring within exon 1), it has a 
number of stop codons. The longest transcript that 




Note: HYAL1 is a secreted somatic tissue 
hyaluronidase, and the predominant hyaluronidase in 
human plasma. Although HYAL1 is predominantly 
secreted, it has an acid pH optimum in vitro. HYAL1 
can degrade high molecular weight hyaluronan to small 
oligomers, primarily to tetrasaccharides, whereas 
HYAL2 (the other major human hyaluronidase) high 
molecular mass hyaluronan to an approximately 20 
kDa product (approximatively 50 saccharide units). 
Description 
Size: 435 amino acids; Molecular mass: 48368 Da. The 
enzyme belongs to the group of carbohydrate-active 
enzymes (http://www.cazy.org/CASy), termed glycosyl 
hydrolase 56 family. 
Expression 
HYAL1 is highly expressed in liver, kidney and heart 
and weakly expressed in lung, placenta and skeletal 
muscle. No expression is detected in adult brain. 
Isoform 1 is expressed only in bladder and prostate 
cancer cells, G2/G3 bladder tumor tissues and lymph 
node specimens showing tumor invasive tumors cells. 
Isoform 3, isoform 4, isoform 5 and isoform 6 are 
expressed in normal bladder and bladder tumor tissues. 
HYAL1 expression has been described in squamous 




It is a secreted enzyme found in plasma and it is also 
present in lysosomes. 
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Function 
It is a hydrolytic enzyme (endo-beta-acetyl-D-
hexosaminidase) with optimum pH about 3.7, acting on 
hyaluronan, chondroitin and chondroitin sulphate. It 
possesses also transglycosidase activity using 
hyaluronan and chondroitin sulphate or chondroitin as 
substrates. This reaction is not well understood, and the 
precise enzymatic mechanism is not known. 
Homology 
The enzyme possesses 70-80% homology to orthologue 
hyaluronidases, 40% homology to paralogue 
hyaluronidases of the human and high homology with 
HYAL1 of other species. 
Mutations 
Somatic 
There are not extended reports regarding mutations of 
HYAL1 gene. The patient with hyaluronidase 
deficiency was a compound heterozygote for two 
mutations in the HYAL1 gene: a 1412G-A mutation 
that introduced a nonconservative amino acid 
substitution (glu268 to lys) in a putative active site 
residue, and a complex intragenic rearrangement, 
1361del37ins14, that resulted in a premature 
termination codon. In addition, the mutated HYAL1 
gene has a markedly different expression pattern than 
the normal one. 
Implicated in 
Mucopolysaccharidosis type IX (MPS9) 
Note: Defects in HYAL1 are the cause of 
mucopolysaccharidosis type IX, also called 
hyaluronidase deficiency. 
Disease 
The clinical features are periarticular soft tissue masses, 
mild short stature and acetabular erosions, absence of 
neurological or visceral involvement and high 
hyaluronan concentration in the serum. 
Cancer 
Note: HYAL1 is inactivated in most lung cancers in a 
conventional manner, by loss of heterozygosity or by 
homozygous deletion, at the DNA level. It is also 
inactivated in many head and neck carcinomas that are 
tobacco-related by aberrant splicing of the mRNA, so 
that only the nontranslatable form is transcribed. In 
addition, the expression of an alternative spliced 
isoform resulting in active enzyme may negatively 
regulate bladder tumor growth, infiltration, and  
angiogenesis. On the other hand, HYAL1 can function 
as oncogene in many cancers of the prostate and 
urinary tract and seems to play important role in 
squamous cell laryngeal carcinoma. 
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